| scholarly article | Q13442814 |
| P356 | DOI | 10.18632/ONCOTARGET.19456 |
| P8608 | Fatcat ID | release_e6d3aivo75a3vkw3p6uw4ozsme |
| P932 | PMC publication ID | 5620308 |
| P698 | PubMed publication ID | 28978168 |
| P2093 | author name string | Xu Min | |
| Chen Pin | |||
| Yu Bo | |||
| Hong Yongzhi | |||
| Shi Xueqiang | |||
| P2860 | cites work | Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients | Q24246372 |
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Occult hepatitis B virus infection | Q27004224 | ||
| Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review | Q33419795 | ||
| Long-term cancer risk of immunosuppressive regimens after kidney transplantation | Q33834315 | ||
| Cancers in renal transplant recipients. | Q33899843 | ||
| Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial | Q34155167 | ||
| Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens | Q34460068 | ||
| Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis | Q34660044 | ||
| Spectrum of cancer risk among US solid organ transplant recipients | Q35848186 | ||
| Cancer incidence after immunosuppressive treatment following kidney transplantation | Q36175004 | ||
| Malignancy after transplantation | Q36298305 | ||
| Post-transplant de novo malignancies in renal transplant recipients: the past and present | Q36530274 | ||
| Health-Risk Factors and the Prevalence of Chronic Kidney Disease: Cross-Sectional Findings from a National Cohort of 87,143 Thai Open University Students | Q36718105 | ||
| Integrating assessment data from multiple informants | Q36813433 | ||
| Cancer in the transplant recipient. | Q36938488 | ||
| Distribution of and factors contributing to chronic kidney disease in a middle-aged working population | Q37299788 | ||
| Cancer and viral infections in immunocompromised individuals | Q37545838 | ||
| Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma | Q37591675 | ||
| Clinical significance of occult hepatitis B virus infection. | Q37862592 | ||
| Why do immunosuppressed patients develop cancer? | Q38216411 | ||
| Cancer incidence before and after kidney transplantation | Q38464934 | ||
| The clinical significance of occult HBV infection | Q42406515 | ||
| Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database | Q42673621 | ||
| Hepatitis C antibody in renal transplant patients | Q42982996 | ||
| The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients | Q42983081 | ||
| Epidemiology, risk factors, and natural history of hepatocellular carcinoma. | Q43038685 | ||
| Viral infection following kidney transplantation: long-term follow-up in a single center | Q43423789 | ||
| Cancer risk after renal transplantation in Japan | Q43816870 | ||
| Impact of hepatitis B and C virus on kidney transplantation outcome | Q44231771 | ||
| Random-effects model for meta-analysis of clinical trials: an update | Q44449763 | ||
| Malignancies after renal transplantation in Taiwan: a nationwide population-based study | Q44616677 | ||
| A human services advocate. Interview by Richard L. Reece | Q44694883 | ||
| Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. | Q45307616 | ||
| Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis | Q45342605 | ||
| Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years | Q45753859 | ||
| Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. | Q45757135 | ||
| Malignancies after kidney transplantation: Hong Kong renal registry | Q46061476 | ||
| Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 | Q56334541 | ||
| Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. The Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis | Q56349517 | ||
| Cancer Incidence Among Canadian Kidney Transplant Recipients | Q57201740 | ||
| Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience | Q58236150 | ||
| Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe | Q58281040 | ||
| Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients | Q59167779 | ||
| Hepatitis C in renal transplant recipients | Q68055331 | ||
| Hepatitis C virus infection and disease in renal transplantation | Q70967114 | ||
| Renal transplantation | Q72442105 | ||
| Hepatitis C virus infection and renal transplantation | Q77088347 | ||
| Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization | Q79811373 | ||
| Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study | Q84780882 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver carcinoma | Q18557387 |
| P304 | page(s) | 68928-68937 | |
| P577 | publication date | 2017-07-22 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | The correlation between renal transplantation and liver carcinoma: a meta-analysis | |
| P478 | volume | 8 |
Search more.